A 2-day-old infant diagnosed with severe erythroblastosis fetalis is admitted to the neonatal intensive care unit. The infant's bilirubin level is 22 mg/dL, and exchange transfusion is planned. What is the priority nursing intervention before the exchange transfusion procedure?

Verifying blood type compatibility is the priority to prevent fatal transfusion reactions. Other actions are important but secondary to ensuring blood product safety.

Clinical Context and Pathophysiology

The infant in this scenario presents with severe erythroblastosis fetalis (hemolytic disease of the newborn) and a critically elevated bilirubin level of 22 mg/dL. At this level, unconjugated bilirubin can cross the immature blood-brain barrier, posing a high risk for kernicterus (bilirubin encephalopathy), which can lead to permanent neurological damage. An exchange transfusion is performed to rapidly remove antibody-coated red blood cells, circulating maternal antibodies, and excess bilirubin. This procedure involves alternately withdrawing small aliquots of the infant's blood and replacing them with donor blood, effectively "exchanging" the infant's circulating blood volume.

Why Verification of Blood Compatibility Is the Priority

Before initiating an exchange transfusion, verifying blood type compatibility and crossmatch results with another nurse is the most critical safety step. This is a high-risk procedure that involves transfusing a significant volume of donor blood, and an ABO or Rh incompatibility reaction in a critically ill neonate can be catastrophic, leading to acute hemolysis, hypotension, renal failure, and death. The dual-verification process serves as an independent double-check, a standard of practice designed to intercept human errors in labeling, sampling, or laboratory processing. The referenced guideline emphasizes that hospitals should develop policies to minimize exposure to multiple donors, which begins with ensuring the correct, compatible unit is prepared and administered the first time ^[1]. A paedipack, which is a single-donor unit divided into multiple smaller aliquots for neonatal use, is typically prepared for this purpose to limit donor exposure, and its use must be immediately communicated to the laboratory ^[1]. Verifying the identity of the recipient and the blood product at the bedside is the foundational step that makes all subsequent safety measures effective.

Analysis of Incorrect Options

- Option 2: Position the infant in a supine position with neck hyperextended. This position is not appropriate for an exchange transfusion. The procedure is typically performed via the umbilical vein using a sterile catheter. The infant is positioned supine with the head in a neutral position to maintain airway patency and secure the catheter site. Hyperextension of the neck would not facilitate umbilical venous access and could compromise the airway.
- Option 3: Administer prophylactic antibiotics as prescribed. While infection prevention is important in the NICU, prophylactic antibiotics are not a standard, immediate pre-procedure requirement specifically for exchange transfusion. The procedure is performed using strict aseptic technique, but antibiotic administration is not a higher priority than ensuring the correct blood product is hung.
- Option 4: Obtain baseline electrolyte levels and complete blood count. Baseline labs, including serum bilirubin, hemoglobin, hematocrit, and electrolyte levels, are essential for monitoring the effectiveness of the exchange and for calculating the volume of blood to be exchanged. However, these labs are typically drawn as part of the pre-procedure workup well before the blood product arrives at the bedside. At the moment immediately before initiating the transfusion, the physical verification of the blood product against the patient's identity and compatibility documentation is the final and most time-sensitive safety check. The guideline supports minimizing phlebotomy where possible through agreed local policies on required tests, but it does not elevate this above the immediate safety check of blood compatibility ^[1].